Skip to content

Using Telehealth to Improve Musculoskeletal Care Through Expanded Physical Therapy Access

Using Telehealth to Improve Musculoskeletal Care Through Expanded Physical Therapy Access: The TELE-MC Trial

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07705945
Acronym
TELE-MC
Enrollment
210
Registered
2026-07-15
Start date
2026-07-01
Completion date
2028-07-01
Last updated
2026-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal Pain

Keywords

musculoskeletal pain, tele-health, stepped care, physical thrapy access, cost-effective care

Brief summary

The purpose of this study is to explore and compare the effectiveness of in-person versus remote physical therapy (PT) for the treatment of musculoskeletal (MSK) pain within the Military Health System (MHS).

Detailed description

This study will explore the effect of remote two-way video conference telehealth physical therapy sessions compared to standard of care in-person physical therapy. Eligible participants will be randomized into one of the 2 treatment arms. Specific aims will compare the effectiveness of physical therapy delivery strategies on the primary outcome of Pain, Enjoyment, and General Activity (PEG-3) Scale, which measures pain interference, and secondary outcomes of PROMIS short forms (mood, physical function, fatigue, sleep disturbance, and prescription medication misuse), patient global impression of change, and pain self-efficacy.

Interventions

OTHERIn-person physical therapy (PT)

Participants assigned to in-person PT will receive individual treatment sessions provided by a licensed, on-site PT. Participants will receive 1-on-1 sessions based on the preference and clinical expertise of the clinician. Participants assigned to in-person physical therapy will receive individual treatment sessions provided by a licensed, on-site physical therapist at the participating military treatment facility. Physical therapists delivering in-person physical therapy will have the option to provide participants a digital home exercise program, however this will not be required. If you choose to download and use either app, you will have to accept the app's terms of service.

OTHERTelehealth physical therapy (TH-PT)

Participants assigned to telehealth physical therapy will use two-way video conferencing with a licensed physical therapist via a secure platform approved for patient care. Video conferencing will be accessible via a mobile app or web browser on your home computer. Participants assigned to telehealth physical therapy will be provided a digital home exercise program. The home exercise program is accessible via a mobile app or web browser on your home computer. This is an app that some military clinics already use as standard of care for providing home exercise programs to their patients, so there is a chance you would be receiving your exercises by this method even if you didn't participate in this study.

Sponsors

Brooke Army Medical Center
Lead SponsorFED
Tripler Army Medical Center
CollaboratorFED
Madigan Army Medical Center
CollaboratorFED
C.R.Darnall Army Medical Center
CollaboratorFED
University of Utah
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

Clinicians and patients cannot be blinded to randomized group assignment. Treatment assignments will be blinded for investigators, assessors, and the lead study statistician. Outcomes assessments will be blinded for investigators, interventionists, and the lead study statistician. Study participants will be blinded to all adherence and fidelity assessments.

Intervention model description

Parallel arm randomized clinical trial

Eligibility

Sex/Gender
ALL
Age
18 Years to 64 Years
Healthy volunteers
No

Inclusion criteria

* Ages 18-64 * TRICARE Beneficiary (active duty, retiree, dependent) * Health care visit for their MSK condition in the past 6 weeks * Diagnosed with an MSK condition that has persisted for at least 2 weeks * Has a computer (either smartphone, tablet or laptop), with video and audio capabilities for telehealth, including access to internet * Able to speak and read English well enough to provide informed consent, follow study instructions and independently answer the questionnaires * Available to attend treatment sessions over the next 2 months

Exclusion criteria

* Surgery for any MSK condition in the past 6 months * Currently known to be pregnant * Medical contraindication to exercise * Currently receiving or scheduled to receive invasive or other nonpharmacologic interventions for any MSK condition (e.g., chiropractic, injections, etc.) with the exception of a physical therapy referral, an issued profile or duty restriction, or other related patient education * Anyone separating from the military within 9 months (other than normal military retirement), pending a medical or physical evaluation board, discharge from the military for medical reasons, or pending or undergoing any litigation for an injury * Signs of serious or systemic pathology that could be responsible for the musculoskeletal pain (i.e. ankylosing spondylitis, rheumatoid arthritis, gout, lupus, vertebral osteomyelitis, or psoriatic arthritis), currently receiving treatment for cancer other than skin cancer or acute fracture (in the last 3 months) of the musculoskeletal region.

Design outcomes

Primary

MeasureTime frameDescription
Pain, Enjoyment, and General Activity Scale (PEG-3)12 WeeksThe PEG-3 measure includes 3 items evaluating 1) pain severity; and interference of pain with 2) enjoyment and 3) general activity. Item response options range from 0-10. The PEG-3 score is expressed as the mean of all item scores ranging from 0-10.

Secondary

MeasureTime frameDescription
PROMIS-2912 WeeksThe PROMIS-29 assesses additional domains relevant to patients with MSK pain including physical function, fatigue, depression, anxiety, pain intensity, ability to participate in social roles, and sleep disturbance. The PROMIS-29 can also be used to calculate a physical and mental health summary score and can be used in cost-effectiveness analyses.
Pain Self-Efficacy Questionnaire (PSEQ)12 WeeksBecause of its role in patients' capacity of selfmanagement, we will use the 10 item Pain Self-Efficacy Questionnaire (PSEQ) to quantify an individual's confidence in performing activities despite pain.
Patient Global Assessment of Change (PGIC)12 WeeksParticipants' satisfaction with their intervention will be based on the single-item Patient Global Assessment of Change (PGIC).
PROMIS Short Form Prescription Pain Medication Misuse26 WeeksThe PROMIS short form 7a assesses the abuse of prescription pain medication. The short form uses fixed items from the PROMIS item bank to provide a T-score with population mean = 50 (sd=10).
EuroQoL (EQ-5D)12 WeeksThe EQ-5D is a generic quality of life questionnaire that will assess quality of life on a scale that can be referenced to other disease conditions. The EQ-5D covers 5 domains: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each domain has 3 response categories: level 1, "no problems"; level 2, "some problems"; and level 3, "inability or extreme problems." Responses are combined to give a 5-digit descriptive health state classification (e.g., 11222). The EQ-5D yields a total of 243 possible health states. Valuations for each health state are available. The EQ-5D is commonly used in economic evaluation of interventions and cost-effectiveness analysis.

Countries

United States

Contacts

CONTACTTina Greenlee, PhD
sammc@militaryclinicalresearch.org210-539-9638
CONTACTCedar Sexton
militaryclinicalresearch@gmail.com210-916-8634

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 16, 2026